Cargando…
The Road to Better Management in Resistant Hypertension—Diagnostic and Therapeutic Insights
Resistant hypertension (R-HTN) implies a higher mortality and morbidity compared to non-R-HTN due to increased cardiovascular risk and associated adverse outcomes—greater risk of developing chronic kidney disease, heart failure, stroke and myocardial infarction. R-HTN is considered when failing to l...
Autores principales: | Bădilă, Elisabeta, Japie, Cristina, Weiss, Emma, Balahura, Ana-Maria, Bartoș, Daniela, Scafa Udriște, Alexandru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153016/ https://www.ncbi.nlm.nih.gov/pubmed/34068168 http://dx.doi.org/10.3390/pharmaceutics13050714 |
Ejemplares similares
-
The Management of Hypertensive Emergencies—Is There a “Magical” Prescription for All?
por: Balahura, Ana-Maria, et al.
Publicado: (2022) -
The riddle of the right ventricle
por: Balahura, Ana-Maria, et al.
Publicado: (2020) -
Diagnosis of Cardiac Abnormalities in Muscular Dystrophies
por: Bădilă, Elisabeta, et al.
Publicado: (2021) -
Cardiovascular Stents: A Review of Past, Current, and Emerging Devices
por: Scafa Udriște, Alexandru, et al.
Publicado: (2021) -
Progress in Biomaterials for Cardiac Tissue Engineering and Regeneration
por: Scafa Udriște, Alexandru, et al.
Publicado: (2023)